Sponsors (2)
Last progress May 14, 2025 (9 months ago)
Introduced on May 14, 2025 by Debbie Dingell
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, Veterans' Affairs, Oversight and Government Reform, and Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Requires the Department of Health and Human Services to set an annual reference price for every prescription drug and prevents the retail list price charged to people in specified federal health programs from exceeding that reference price. The Secretary must base reference prices on the lowest price among specified foreign countries when available (minimum three countries) or on a multifactored domestic formula when international prices are not available.
Manufacturers must offer their drugs at the reference price to all individuals (including uninsured and people with group coverage). Manufacturers that fail to comply face civil monetary penalties, and collected penalty funds are directed to the National Institutes of Health to support drug research.
Updated 5 hours ago
Last progress May 14, 2025 (9 months ago)